<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37517821</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-5364</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Chinese journal of natural medicines</Title><ISOAbbreviation>Chin J Nat Med</ISOAbbreviation></Journal><ArticleTitle>Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-&#x3ba;B/Bcl-2 pathway.</ArticleTitle><Pagination><StartPage>540</StartPage><EndPage>550</EndPage><MedlinePgn>540-550</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1875-5364(23)60445-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1875-5364(23)60445-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting both upper and lower motor neurons in the brain and spinal cord. One important aspect of ALS pathogenesis is superoxide dismutase 1 (SOD1) mutant-mediated mitochondrial toxicity, leading to apoptosis in neurons. This study aimed to evaluate the neural protective synergistic effects of ginsenosides Rg1 (G-Rg1) and conditioned medium (CM) on a mutational SOD1 cell model, and to explore the underlying mechanisms. We found that the contents of nerve growth factor, glial cell line-derived neurotrophic factor, and brain-derived neurotrophic factor significantly increased in CM after human umbilical cord mesenchymal stem cells (hUCMSCs) were exposed to neuron differentiation reagents for seven days. CM or G-Rg1 decreased the apoptotic rate of SOD1<sup>G93A</sup>-NSC34 cells to a certain extent, but their combination brought about the least apoptosis, compared with CM or G-Rg1 alone. Further research showed that the anti-apoptotic protein Bcl-2 was upregulated in all the treatment groups. Proteins associated with mitochondrial apoptotic pathways, such as Bax, caspase 9 (Cas-9), and cytochrome c (Cyt c), were downregulated. Furthermore, CM or G-Rg1 also inhibited the activation of the nuclear factor-kappa B (NF-&#x3ba;B) signaling pathway by reducing the phosphorylation of p65 and I&#x3ba;B&#x3b1;. CM/G-Rg1 or their combination also reduced the apoptotic rate induced by betulinic acid (BetA), an agonist of the NF-&#x3ba;B signaling pathway. In summary, the combination of CM and G-Rg1 effectively reduced the apoptosis of SOD1<sup>G93A</sup>-NSC34 cells through suppressing the NF-&#x3ba;B/Bcl-2 signaling pathway (Fig. 1 is a graphical representation of the abstract).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Labortory of Stem Cell Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Biying</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guiling</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Labortory of Stem Cell Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Labortory of Stem Cell Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DU</LastName><ForeName>Baoxin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Labortory of Stem Cell Clinical Reaearch, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Labortory of Stem Cell Biology and Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China. Electronic address: dbx.dr@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin J Nat Med</MedlineTA><NlmUniqueID>101504416</NlmUniqueID><ISSNLinking>1875-5364</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>PJ788634QY</RegistryNumber><NameOfSubstance UI="C035054">ginsenoside Rg1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036145">Ginsenosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036145" MajorTopicYN="Y">Ginsenosides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">Conditioned medium</Keyword><Keyword MajorTopicYN="N">Ginsenoside-Rg1</Keyword><Keyword MajorTopicYN="N">Umbilical cord mesenchymal stem cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>30</Day><Hour>20</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37517821</ArticleId><ArticleId IdType="doi">10.1016/S1875-5364(23)60445-5</ArticleId><ArticleId IdType="pii">S1875-5364(23)60445-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>